Purpose To report long-term (> 4 years) toxicity and quality of life (QoL) among patients with
nasopharyngeal carcinoma (NPC) treated with intensity modulated radiation therapy (IMRT) …

Background and purpose To determine rates of xerostomia after intensity-modulated
radiotherapy (IMRT) or intensity-modulated proton therapy (IMPT) for oropharyngeal cancer …

Objective Radiotherapy‐induced xerostomia (RIX) is one of the most common adverse
effects of radiotherapy to the head and neck, and a major determinant of survivors' quality of …

Objectives There is little research on the patient experience of symptom burden from CAR T-
cell therapy, and no validated measure specific to the symptoms of CAR T-cell therapy …

Background This study was conducted to identify clinicodemographic risk factors for
xerostomia among long‐term oropharyngeal cancer (OPC) survivors. Methods This cross …

Purpose To assess associations between a variety of patient-reported outcomes (PROs),
observer reported toxicities (ORTs), and patient-reported overall quality of life (QOL) for …

Purpose Before and after treatment for head and neck cancer (HNC), many patients have
problems with mastication, swallowing, and salivary flow. The aim of this study was to …

Purpose We report longitudinal patient-reported quality-of-life (QoL) outcomes related to
xerostomia in patients with oropharyngeal cancer treated with intensity-modulated proton …

Significance: Orofacial structures are indispensable for speech and eating, and impairment
disrupts whole-body health through malnutrition and poor quality of life. However, due to the …

Background This study reports long‐term head and neck cancer (HNC) patient‐reported
symptoms using the MD Anderson Symptom Inventory Head and Neck Cancer Module …